Picture of Arix Bioscience logo

ARIX Arix Bioscience News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsConservativeSmall CapMomentum Trap

REG - Arix Bioscience Plc - Company Secretary Change

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220224:nRSX6350Ca&default-theme=true

RNS Number : 6350C  Arix Bioscience Plc  24 February 2022

 

24 February 2022

 

Arix Bioscience plc

Appointment of Company Secretary

Arix Bioscience plc ("Arix" or the "Company") a global venture capital company
focused on investing in and building breakthrough biotech companies, today
announces the appointment of Derringtons Limited as Company Secretary with
immediate effect. Derringtons will take over the role from the company's CEO
and General Counsel, Robert Lyne, who consequently will relinquish his
additional responsibilities as Company Secretary to focus on the core
operations of the business.

Derringtons are a team of qualified Company Secretaries, with over 30 years of
combined experience who deliver professional company secretarial services and
provide independent governance advice to both private and listed companies and
who have extensive experience in supporting listed investment trusts and
operating companies.

 

Ends.

 

 

For further information please contact:

Derringtons Limited, Company Secretary

+44 20 8819 6486

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  COSSEFESDEESELE

Recent news on Arix Bioscience

See all news